ANDOVER, Mass.--(BUSINESS WIRE)--March 1, 2005--Royal Philips Electronics (NYSE:PHG)(AEX:PHI) today announced U.S. Food and Drug Administration (FDA) clearance for its HeartStart FRx Defibrillator that is designed for reliability, exceptional ruggedness, and ease of use. This automated external defibrillator (AED) is targeted at those who first get to a victim of sudden cardiac arrest (SCA) -- and potentially save a life. The Philips HeartStart FRx Defibrillator was designed to be versatile enough to handle extreme weather and various environmental conditions, and easy enough to be used successfully by responders who have minimal AED training.
